Akèy › Limfadenopati Imunoblastik › Massachusetts › Boston
Etid klinik pou Limfadenopati Imunoblastik nan Boston, MA
3 etid pou Limfadenopati Imunoblastik ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Ap rekriteFaz 2
- Dana-Farber Cancer Institute, Boston
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Ap rekriteFaz 3
- Massachusetts General Hospital, Boston
A Registry for People With T-cell Lymphoma
Ap rekriteEtid obsèvasyon
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
Etid Limfadenopati Imunoblastik nan lòt vil
- New York City, NY5 etid
- Chicago, IL4 etid
- Houston, TX4 etid
- Miami, FL4 etid
- Durham, NC4 etid
- Baldwin Park, CA3 etid
- Ann Arbor, MI3 etid
- New Haven, CT3 etid
- Columbus, OH3 etid
- Atlanta, GA3 etid
- St. Louis, MO3 etid
- Rochester, MN3 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.